CTD-T AM 6.25/80/5 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Telmisartan (80mg) + Amlodipine (5mg) + Chlorthalidone (6.25mg)
Overview CTD-T AM 6.25/80/5 Tablet
The combined medication CTD-T AM 6.25/80/5 Tablet effectively manages hypertension (high blood pressure) in cases where single-agent therapy proves insufficient. By lowering elevated blood pressure, it significantly reduces the risk of future strokes and heart attacks. Administer this tablet with food, at the same time daily, and continue as directed by your physician. Dosage is individualized. The formulation includes a diuretic, increasing urination; therefore, avoid dosing within four hours of bedtime. Consistent use, even during symptom-free periods, is crucial for optimal therapeutic effect. Discontinuing treatment may heighten the risk of cardiovascular events. Common side effects include fatigue, altered taste, dizziness, headache, and ankle edema. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Maintain adequate hydration to mitigate potential side effects such as dry mouth, thirst, and muscle weakness. Prior to initiating treatment, inform your physician about any kidney or liver conditions, pregnancy, breastfeeding, or other medications you are currently taking, particularly those for heart or blood pressure management. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure treatment efficacy and safety.
Primary Ingredients of CTD-T AM 6.25/80/5 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of CTD-T AM 6.25/80/5 Tablet
Elevated blood pressure
Major Benefits of CTD-T AM 6.25/80/5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-T AM 6.25/80/5 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of CTD-T AM 6.25/80/5 Tablet:
- Headache
- Dizziness
- Sleepiness
- Edema (swelling)
- Increased uric acid level in blood
- Fatigue
- Increased blood lipid level
- Increased liver enzymes
- Visual disturbance
- Breathlessness
- Muscle cramp
- Gastrointestinal disturbance
- Electrolyte imbalance
- Increased glucose level in blood
- Urticaria
- Postural hypotension (low blood pressure)
- Impotence
How to use CTD-T AM 6.25/80/5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-T AM 6.25/80/5 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How CTD-T AM 6.25/80/5 Tablet works:
The tablet CTD-T AM 6.25/80/5 combines telmisartan, amlodipine, and chlorthalidone to manage blood pressure. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both act to dilate blood vessels, reducing blood pressure. Chlorthalidone, a diuretic, facilitates fluid and electrolyte excretion, contributing to lower blood pressure through enhanced blood vessel dilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining CTD-T AM 6.25/80/5 Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of CTD-T AM 6.25/80/5 Tablet is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The medication CTD-T AM 6.25/80/5 Tablet is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of CTD-T AM 6.25/80/5 Tablets. These potential side effects include dizziness, headaches, nausea, or fatigue, any of which can reduce concentration and driving aptitude.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using CTD-T AM 6.25/80/5 tablets, as dose modification may be necessary. Physician consultation is advised; indeed, its use is generally discouraged in such cases.
LiverCAUTION
Patients with liver impairment should use CTD-T AM 6.25/80/5 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. CTD-T AM 6.25/80/5 Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take CTD-T AM 6.25/80/5 Tablet :
Should you forget to take your CTD-T AM 6.25/80/5 Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CTD-T AM 6.25/80/5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





